Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 1372 results for patients and public

  1. Image-guided percutaneous laser ablation for primary and secondary liver tumours (IPG788)

    Evidence-based recommendations on image-guided percutaneous laser ablation for primary and secondary liver tumours. This involves heating up liver tissue to destroy tumours.

    Interventional procedures guidance
    Published
    16 May 2024
    View recommendations

    Sections for IPG788

  2. Technology appraisal committee

    Details, meeting dates and minutes of the independent technology appraisal committees

  3. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation

  4. Our projects and partners

    NICE research projects and partners.

  5. Board

    Our board sets out our strategic priorities and policies.

  6. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.

    COVID-19 rapid guideline
    Last updated
    8 May 2024

    Sections for NG191

  7. Medical technologies advisory committee members

    working closely across all tiers of the trust to improve the delivery of safe patient care. He is also the Acute Care Common Stem...

  8. Structure of NICE

    NHS, local government, social care, patients and their families. Responsible for: clinical guidelines public health...

  9. Indicator advisory committee (IAC)

    and secondary care professionals commissioners public health and social care professionals patients or service users and...

  10. Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma in people 3 years and over (TA967)

    Evidence-based recommendations on pembrolizumab (Keytruda) for relapsed or refractory classical Hodgkin lymphoma in people 3 years and over.

    Technology appraisal guidance
    Published
    1 May 2024
    View recommendations

    Sections for TA967

  11. Notify a procedure

    Tell us about an interventional procedure you think should be assessed by NICE.

  12. Highly specialised technologies evaluation committee

    Members are appointed for a 3-year term, and are drawn from: the NHS patient and carer organisations academia pharmaceuticals and...

  13. Lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema (IPG785)

    Evidence-based recommendations on lymphovenous anastomosis during axillary or inguinal node dissection for preventing secondary lymphoedema in adults. This involves diverting some of the lymphatic vessels around where lymph nodes have been removed to nearby veins.

    Interventional procedures guidance
    Published
    16 April 2024
    View recommendations

    Sections for IPG785

  14. Executive team

    Biographies of the NICE executive team and minutes of their meetings

  15. Committee D members

    Find out more about NICE technology appraisals advisory committee D members